Big pharma has an interest in rich people being sick | Giles Fraser

What profit is there in a healthy population? If everyone were healthy, it would be the job of the pharmaceutical companies to persuade us that we were not well

The giant pharmaceutical company GlaxoSmithKline said yesterday that its work on a vaccine for Ebola will come too late to do anything about the current situation. Even now it is trying to compress trials that would normally take a decade into a year. The impression it gives is that it is working flat out, no holds barred. But hang on a moment. Ebola was discovered back in 1976. What has GlaxoSmithKline been doing since then? Answer: not much.

A small clue to why can be found by looking at the stock price of Tekmira Pharmaceuticals, the Canadian-based drugs firm that some investors seem to think is leading the pack on Ebola research. Tekmira shares rose a massive 180% from mid-July to October, with most of the share-price action coming when the virus jumped to Europe and the US.

Continue reading…
Pharmaceuticals industry | The Guardian

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us